NPPA issued a notification regarding the fixation of retail price of Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg + Metformin Hydrochloride IP 1000mg + Glimepiride IP 1mg

Jul 25, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on July 23, 2024, issued a notification regarding the fixation of the retail price of Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg + Metformin Hydrochloride IP 1000mg + Glimepiride IP 1mg.

The following has been stated: -

• The price is computed on the basis of data from November 2023

• The price is computed for each Film-coated tablet containing Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg + Metformin Hydrochloride IP 1000mg + Glimepiride IP 1mg for M/s Synokem Pharmaceuticals Ltd (Manufacturer) & M/s Apex Laboratories Pvt Ltd

• The Total MAT is 3,83,800

[Notification No. 19(4097)/2024/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT